Stock A141080 LIGACHEM BIOSCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases LigaChem Biosciences Inc.

Equities

A141080

KR7141080002

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
69,000 KRW +2.53% Intraday chart for LigaChem Biosciences Inc. +8.32% +6.15%
May. 16 LigaChem Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 08 NextCure, Inc. and LigaChem Biosciences, Inc. Present Preclinical Data on B7-H4 Antibody Drug Conjugate At AACR 2024 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Samsung Biologics partners with LegoChem Biosciences for ADC development and manufacturing
AQ
LegoChem Biosciences Selects BostonGene as Genomic Partner for First-in-Human Clinical Trial
AQ
LegoChem Biosciences : WuXi XDC and LegoChem Biosciences sign Memorandum of Understanding
AQ
Legochem Biosciences : CStone and LegoChem Biosciences Enter Global Licensing Agreement for New Antibody Drug Conjugate
AQ
LegoChem Biosciences : and Takeda Enter into a Multi-Target Research Collaboration and License Agreement for the Development of Antibody-Drug Conjugates in Immuno-Oncology
BU
LegoChem Biosciences : Receives US Patent for Its Own Proprietary ADC Platform Technology ConjuAllTM
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A141080 Stock
  4. News LigaChem Biosciences Inc.
  5. Press Releases